Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generation and Cognitive Testing of Informative and Suitable Items for a COPD Exacerbation Recognition Tool (CERT) for Detection of Exacerbations of COPD in Chinese Patients

NCT03170999 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03170999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03170999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generation and Cognitive Testing of Informative and Suitable Items for a COPD Exacerbation Recognition Tool (CERT) for Detection of Exacerbations of COPD in Chinese Patients
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 29, 2018
Completion date
May 29, 2020
Enrollment
199 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

airway obstruction